High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma

BACKGROUND: HMGA2 expression has been shown to be associated with enhanced selective chemosensitivity towards the topoisomerase (topo) II inhibitor, doxorubicin, in cancer cells. Although the roles of signaling cascades and proteins as regulatory factors in development, neoplasia and adaptation to t...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Hebert, Carla, Norris, Kathleen, Scheper, Mark A, Nikitakis, Nikolaos, Sauk, John J
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2007
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC1783857/
https://ncbi.nlm.nih.gov/pubmed/17222355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-6-5
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia